U.S., Sept. 13 -- ClinicalTrials.gov registry received information related to the study (NCT07171489) titled 'Efficacy of a Wearable Noninvasive Neuromodulation Device' on Sept. 05.
Brief Summary: The aim of this study is to investigate the potential of transcutaneous neuromodulation (TNM) to treat slow colonic transit and constipation, termed the Neurogenic bowel dysfunction (NBD), in people with SCI. In this project, the study team will investigate the impact of an active treatment intervention vs. a sham control intervention on NBD symptoms in patients with SCI.
The study hypotheses:
* The proposed TNM treatment at a leg point will reduce NBD symptoms between baseline and post-therapy, when compared to the sham-TNM treatment.
* The t...